Huntington’s disease has been successfully treated for the first time using a gene therapy, which may be available in the US ...

For the first time, scientists have successfully treated someone suffering from Huntington's disease, a fatal genetic illness with no cure.

The company behind the experimental treatment says it plans to submit its data seeking approval to U.S. regulators in the first quarter of next year.

In the complex world of neuroscience, Huntington's disease remains a cruel mystery. It slowly strips away a person’s ability to think and move, yet scientists still don't fully understand why.

Huntington’s disease is a neurological (brain) condition that causes involuntary movement, changes to emotions, behavior, and thinking. Huntington’s is a genetic disease that worsens over time.

UniQure's therapy, called AMT-130, reduced disease progression by 75% at 36 months in patients who received a high dose.

The first signs of Huntington’s disease are often subtle changes in coordination, such as clumsiness or trouble with balance. You may also begin to notice changes in thinking, such as difficulty ...

LITTLE ROCK, Ark. (KATV) — The Huntington's Disease Society of America is organizing the Team Hope Walk in Arkansas to raise awareness and support for those affected by Huntington's disease, a rare ...

uniQure N.V. has announced progress regarding its investigational gene therapy AMT-130 for Huntington's disease, aligning with the FDA on key components necessary for a Biologics License Application ...